First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure-Reference-Cited by-同舟云学术

First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure

Published:2024-03 Issue:7 Volume:187 Page:1666-1684.e26
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Zwirner Stefan,Abu Rmilah Anan A.,Klotz Sabrina,Pfaffenroth Bent,Kloevekorn Philip,Moschopoulou Athina A.,Schuette Svenja,Haag Mathias,Selig Roland,Li Kewei,Zhou Wei,Nelson Erek,Poso Antti,Chen Harvey,Amiot Bruce,Jia Yao,Minshew Anna,Michalak Gregory,Cui Wei,Rist Elke,Longerich Thomas,Jung Birgit,Felgendreff Philipp,Trompak Omelyan,Premsrirut Prem K.,Gries Katharina,Muerdter Thomas E.,Heinkele Georg,Wuestefeld Torsten,Shapiro David,Weissbach Markus,Koenigsrainer Alfred,Sipos Bence,AB Eiso,Zacarias Magdalena Ortiz,Theisgen Stephan,Gruenheit Nicole,Biskup Saskia,Schwab Matthias,Albrecht Wolfgang,Laufer Stefan,Nyberg Scott,Zender Lars^ORCID

Funder

Robert-Bosch Foundation GmbH

German Research Foundation

German Cancer Consortium

Publisher

Elsevier BV

Reference82 articles.

1. Burden of liver diseases in the world;Asrani;J. Hepatol.,2019

2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Gastroenterol. Hepatol.,2020

3. Liver regeneration and inflammation: from fundamental science to clinical applications;Campana;Nat. Rev. Mol. Cell Biol.,2021

4. A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration;Wuestefeld;Cell,2013

5. Diversity and versatility of p38 kinase signalling in health and disease;Canovas;Nat. Rev. Mol. Cell Biol.,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations;Clinical and Translational Medicine;2024-08

2. Fisetin is a selective adenosine triphosphate‐competitive inhibitor for mitogen‐activated protein kinase kinase 4 to inhibit lipopolysaccharide‐stimulated inflammation;BioFactors;2024-08

3. Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review;Medical Science Monitor;2024-07-23

4. Actual perspectives on LDLT in Europe;Updates in Surgery;2024-07-04

5. Boosting liver regeneration: kinase inhibitor as a new tool to prevent liver failure;Signal Transduction and Targeted Therapy;2024-07-03